StockData
Lifevantage Corp logo

Lifevantage Corp (LFVN) stock

LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 20/3044% below fair value
$4.78+0.01 (+0.21%)

Close on Nov 17, 2026Market cap $59.88MP/E 11.9Yield 3.87%

Lifevantage operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Lifevantage's operating cash flow for the twelve months ending Jun 30, 2026 was $10.24M, down 13.8% year over year. For fiscal 2026 it was $10.24M, down 13.8% from the year before. Over ten years it grew 5.4% a year on average. The highest annual figure on record is $19.39M in fiscal 2012.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026$10.24M-13.8%
FY2025Jun 30, 2025$11.88M-2.6%
FY2024Jun 30, 2024$12.20M+78.6%
FY2023Jun 30, 2023$6.83M-14.2%
FY2022Jun 30, 2022$7.96M-51.1%
FY2021Jun 30, 2021$16.27M-11.2%
FY2020Jun 30, 2020$18.33M+3.0%
FY2019Jun 30, 2019$17.79M+34.2%
FY2018Jun 30, 2018$13.26M+100.9%
FY2017Jun 30, 2017$6.60M+9.3%
FY2016Jun 30, 2016$6.04M-54.3%
FY2015Jun 30, 2015$13.22M+9.2%
FY2014Jun 30, 2014$12.11M+13.5%
FY2013Jun 30, 2013$10.66M-45.0%
FY2012Jun 30, 2012$19.39M+314.2%
FY2011Jun 30, 2011$4.68M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$4.77M+361.0%
Q3 FY2026CQ1 2026Mar 31, 2026$4.99M+123.9%
Q2 FY2026CQ4 2025Dec 31, 2025$2.79M-69.7%
Q1 FY2026CQ3 2025Sep 30, 2025-$2.31M–
Q4 FY2025CQ2 2025Jun 30, 2025$1.03M-60.0%
Q3 FY2025CQ1 2025Mar 31, 2025$2.23M-28.0%
Q2 FY2025CQ4 2024Dec 31, 2024$9.20M+423.6%
Q1 FY2025CQ3 2024Sep 30, 2024-$583.00K-112.2%
Q4 FY2024CQ2 2024Jun 30, 2024$2.58M-31.4%
Q3 FY2024CQ1 2024Mar 31, 2024$3.09M-10.2%
Q2 FY2024CQ4 2023Dec 31, 2023$1.76M+81.7%
Q1 FY2024CQ3 2023Sep 30, 2023$4.77M–
Q4 FY2023CQ2 2023Jun 30, 2023$3.76M+35.4%
Q3 FY2023CQ1 2023Mar 31, 2023$3.44M+413.1%
Q2 FY2023CQ4 2022Dec 31, 2022$967.00K-76.1%
Q1 FY2023CQ3 2022Sep 30, 2022-$1.35M-389.2%
Q4 FY2022CQ2 2022Jun 30, 2022$2.78M-66.8%
Q3 FY2022CQ1 2022Mar 31, 2022$671.00K-78.1%
Q2 FY2022CQ4 2021Dec 31, 2021$4.04M-31.4%
Q1 FY2022CQ3 2021Sep 30, 2021$465.00K–
Q4 FY2021CQ2 2021Jun 30, 2021$8.37M-10.4%
Q3 FY2021CQ1 2021Mar 31, 2021$3.06M-4.8%
Q2 FY2021CQ4 2020Dec 31, 2020$5.89M-36.1%
Q1 FY2021CQ3 2020Sep 30, 2020-$1.05M–
Q4 FY2020CQ2 2020Jun 30, 2020$9.35M+33.9%
Q3 FY2020CQ1 2020Mar 31, 2020$3.21M-16.9%
Q2 FY2020CQ4 2019Dec 31, 2019$9.23M+101.6%
Q1 FY2020CQ3 2019Sep 30, 2019-$3.46M-246.2%
Q4 FY2019CQ2 2019Jun 30, 2019$6.98M+27.7%
Q3 FY2019CQ1 2019Mar 31, 2019$3.86M+24.5%
Q2 FY2019CQ4 2018Dec 31, 2018$4.58M+110.0%
Q1 FY2019CQ3 2018Sep 30, 2018$2.37M-5.5%
Q4 FY2018CQ2 2018Jun 30, 2018$5.47M+176.9%
Q3 FY2018CQ1 2018Mar 31, 2018$3.10M–
Q2 FY2018CQ4 2017Dec 31, 2017$2.18M-1.8%
Q1 FY2018CQ3 2017Sep 30, 2017$2.50M-13.1%
Q4 FY2017CQ2 2017Jun 30, 2017$1.98M–
Q3 FY2017CQ1 2017Mar 31, 2017-$479.00K–
Q2 FY2017CQ4 2016Dec 31, 2016$2.22M–
Q1 FY2017CQ3 2016Sep 30, 2016$2.88M–

More Lifevantage figures

See a number that looks wrong?